Australia Infant Phototherapy Device Market Size and Forecast 2025–2033

The Australia Infant Phototherapy Device Market is estimated to reach US$ 2.47 billion by 2033 from US$ 1.88 billion in 2024, growing at a CAGR of 3.1% between 2025 and 2033. Growth is driven by rising cases of neonatal jaundice, increased awareness of early infant healthcare, and advances in non-invasive phototherapy technologies used in hospitals and neonatal intensive care units (NICUs).

Market Overview Infant phototherapy devices treat neonatal jaundice by emitting blue light (460–490 nm) to break down excess bilirubin safely and non-invasively. Usage is widespread in Australian maternity wards and hospitals, supported by strong healthcare infrastructure and government initiatives promoting neonatal health. LED-based devices are preferred for energy efficiency, lower heat emission, and improved infant comfort. The market is further strengthened by the introduction of mobile phototherapy units for rural outreach and home care, enhancing access across urban and remote regions.

Key Growth Drivers

Rising Neonatal Jaundice Cases: Premature births and liver immaturity make jaundice common among newborns. Early diagnosis and treatment in hospitals are increasing demand for phototherapy devices.

Technological Advancements: LED units, fiber-optic blankets, and devices with intensity controls improve treatment efficacy, energy efficiency, portability, and infant safety. Replacement of fluorescent units with LED-based devices is accelerating adoption.

Government Support and Healthcare Infrastructure: Public funding, hospital procurement programs, and staff training ensure proper device use and wider access, particularly in rural and underserved areas.

Market Challenges

High Equipment Costs: Advanced LED-based devices can be expensive, limiting adoption in small clinics and rural hospitals. Budget constraints may lead to continued use of outdated machines.

Limited Access in Remote Populations: Indigenous and remote communities face barriers to timely treatment, necessitating mobile units and outreach programs to bridge the gap.

Market Segmentation

Light Source: Fluorescent Lamps, LEDs, Quartz Halogen Lamps, Gas Discharge Tubes

Configuration: Mobile Device, Fixed Device

End User: Hospitals, Neonatal Clinics

Top States: New South Wales, Victoria, Queensland, Western Australia, South Australia, Tasmania, Northern Territory, Australian Capital Territory

Key Players Ningbo David Medical Device Co., Ltd, Koninklijke Philips N.V., General Electric Company, Inspiration Healthcare Group Plc, Drägerwerk AG & Co. KGaA, Ibis Medical Equipment and Systems Pvt Ltd, Weyer GmbH, Natus Medical Incorporated

Australia’s infant phototherapy device market is expected to grow steadily, driven by advanced technologies, rising neonatal health awareness, and government initiatives, while addressing challenges of high costs and accessibility in remote regions.